AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $161,000 | -9.6% | 13,941 | -25.1% | 0.00% | – |
Q3 2021 | $178,000 | +38.0% | 18,613 | +42.8% | 0.00% | – |
Q1 2021 | $129,000 | -43.7% | 13,035 | +31.4% | 0.00% | – |
Q4 2020 | $229,000 | -51.2% | 9,917 | -70.2% | 0.00% | -100.0% |
Q3 2020 | $469,000 | -6.9% | 33,235 | -0.6% | 0.00% | 0.0% |
Q2 2020 | $504,000 | +81.3% | 33,448 | +11.0% | 0.00% | 0.0% |
Q1 2020 | $278,000 | +180.8% | 30,128 | +196.4% | 0.00% | – |
Q4 2019 | $99,000 | +3.1% | 10,163 | -15.2% | 0.00% | – |
Q3 2019 | $96,000 | -40.4% | 11,985 | -6.9% | 0.00% | – |
Q2 2019 | $161,000 | -17.4% | 12,872 | -10.2% | 0.00% | – |
Q1 2019 | $195,000 | +33.6% | 14,338 | -5.9% | 0.00% | – |
Q4 2018 | $146,000 | -24.0% | 15,233 | -4.1% | 0.00% | – |
Q3 2018 | $192,000 | -19.7% | 15,877 | +3.8% | 0.00% | -100.0% |
Q2 2018 | $239,000 | +1.3% | 15,294 | -2.6% | 0.00% | 0.0% |
Q1 2018 | $236,000 | +5.4% | 15,697 | +1.0% | 0.00% | 0.0% |
Q4 2017 | $224,000 | -3.9% | 15,546 | +0.5% | 0.00% | 0.0% |
Q3 2017 | $233,000 | +356.9% | 15,465 | +54.6% | 0.00% | – |
Q4 2016 | $51,000 | -36.2% | 10,000 | -9.1% | 0.00% | -100.0% |
Q3 2016 | $80,000 | +29.0% | 11,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $62,000 | -66.5% | 11,000 | -50.0% | 0.00% | 0.0% |
Q1 2016 | $185,000 | -8.9% | 22,000 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $203,000 | +136.0% | 22,000 | +75.4% | 0.00% | – |
Q3 2015 | $86,000 | – | 12,543 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |